NCT06212882

Brief Summary

The investigators aimed to compare the image quality and diagnostic performance of DECTPA using lower concentration iodine contrast materials and using normal concentration iodine contrast materials in the evaluation of suspected pulmonary embolism.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,100

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 19, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

January 19, 2024

Status Verified

January 1, 2024

Enrollment Period

1.2 years

First QC Date

December 18, 2023

Last Update Submit

January 18, 2024

Conditions

Keywords

pulmonary embolismComputed Tomographycontrast materials

Outcome Measures

Primary Outcomes (1)

  • image quality evaluation of the CTPA images of 30% participants

    1. the mean CT number (in Hounsfield units) in the main pulmonary artery by using a region of interest of at least 1 square centimeter. 2. the CT number (in Hounsfield units) of peripheral pulmonary arteries close to the beginning and the end of each scan in a egmental or subsegmental artery at an apical and a basal section position. Because the caliber of the peripheral vessels was too small to reliably set an intraluminal region of interest to determine the mean CT number, the maximum CT number as a proxy for vascular attenuation should be chosen. 3. the images quality score for making a diagnosis other than PE ( using a five-point scale ranging from 1 to 5).

    through the CTPA examinations of 30% participants finished,, an average of six month

Secondary Outcomes (1)

  • overall diagnostic performance for pulmonary embolism

    CTPA examinations all participants are finished, an average of two month

Study Arms (3)

Lower concentration and lower volume contrast agent group

Diagnostic Test: Lower concentration and lower volume contrast agent group

Lower concentration and normal volume contrast agent group

Diagnostic Test: Lower concentration and lower volume contrast agent group

Normal concentration and normal volume contrast agent group

Interventions

CT images using lower concentration and lower volume contrast material

Lower concentration and lower volume contrast agent groupLower concentration and normal volume contrast agent group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients who will undergo CT pulmonary angiography due to clinical suspicion of pulmonary embolism

You may qualify if:

  • Age greater than 18 years old
  • Clinical suspicion of pulmonary embolism suggests CTPA examination (Wells score\>4 or D-2 polymer elevation)
  • Patient's general physical condition tolerates CTPA examination

You may not qualify if:

  • Allergy to iodine contrast agents
  • Hyperthyroidism
  • Pregnancy
  • Weight greater than 80kg
  • Heart failure patients, NYHA heart function level III or IV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuxi People's Hospital

Wuxi, Jiangsu, 214043, China

RECRUITING

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Central Study Contacts

Xiangming Fang, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Scientific Research Department

Study Record Dates

First Submitted

December 18, 2023

First Posted

January 19, 2024

Study Start

September 1, 2023

Primary Completion

November 1, 2024

Study Completion

June 1, 2025

Last Updated

January 19, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

index that measuring image quality and pulmonary embolism CTPA diagnostic results for each individual

Shared Documents
STUDY PROTOCOL
Time Frame
After the main paper is published.
Access Criteria
application from the Central Contact Person

Locations